AMOXICILLIN AND CLAVULANATE POTASSIUM (amoxicillin and clavulanate potassium) by Deva Holdings is drug. Approved for the following infections in adults, skin structure infections urinary tract infections limitations of use, indicating no beta-lactamase production and 10 more indications. First approved in 2023.
Drug data last refreshed 23h ago
drug. [see Microbiology ]
Worked on AMOXICILLIN AND CLAVULANATE POTASSIUM at Deva Holdings? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.